Art
J-GLOBAL ID:201402276283187745   Reference number:14A0484946

The Recent Trends in the Use of Angiotensin II Receptor Blockers

「循環器系薬剤のトレンド 2」アンジオテンシンII受容体拮抗薬
Author (3):
Material:
Volume: 73  Issue:Page: 8-11  Publication year: Feb. 01, 2014 
JST Material Number: F0911A  ISSN: 0029-0424  CODEN: NICHA  Document type: Article
Article type: 解説  Country of issue: Japan (JPN)  Language: JAPANESE (JA)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=14A0484946&from=J-GLOBAL&jstjournalNo=F0911A") }}
JST classification (1):
JST classification
Category name(code) classified by JST.
Clinical application of vasoactive drugs and hypotensive drugs 
Reference (22):
  • 1) Sezai A, Soma M, Hata M, et al. Effects of olmesartan on the renin-angiotensin-aldosterone system for patients with essential hypertension after cardiac surgery-investigation using a candesartan change-over study. Ann Thorac Cardiovasc Surg 2011; 17: 487-493.
  • 2) Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345: 861-869.
  • 3) Pfeffer MA, Swedberg K, Granger CB, et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet 2003; 362: 759-766.
  • 4) McMurray JJ, Ostergren J, Swedberg K, et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARMAdded trial. Lancet 2003; 362: 767-771.
  • 5) Granger CB, McMurray JJ, Yusuf S, et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARMAlternative trial. Lancet 2003; 362: 772-776.
more...
Terms in the title (4):
Terms in the title
Keywords automatically extracted from the title.

Return to Previous Page